X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TTK HEALTHCARE - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TTK HEALTHCARE NOVARTIS/
TTK HEALTHCARE
 
P/E (TTM) x 289.6 17.7 1,640.5% View Chart
P/BV x 32.1 5.7 559.2% View Chart
Dividend Yield % 1.4 0.5 281.3%  

Financials

 NOVARTIS   TTK HEALTHCARE
EQUITY SHARE DATA
    NOVARTIS
Mar-18
TTK HEALTHCARE
Mar-14
NOVARTIS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs758663 114.3%   
Low Rs579399 145.1%   
Sales per share (Unadj.) Rs228.4535.6 42.6%  
Earnings per share (Unadj.) Rs31.715.9 199.0%  
Cash flow per share (Unadj.) Rs32.820.0 163.6%  
Dividends per share (Unadj.) Rs10.004.00 250.0%  
Dividend yield (eoy) %1.50.8 198.7%  
Book value per share (Unadj.) Rs297.1137.6 215.9%  
Shares outstanding (eoy) m24.697.77 317.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.0 295.1%   
Avg P/E ratio x21.133.3 63.2%  
P/CF ratio (eoy) x20.426.5 76.9%  
Price / Book Value ratio x2.23.9 58.3%  
Dividend payout %31.525.1 125.6%   
Avg Mkt Cap Rs m16,5054,127 399.9%   
No. of employees `0000.71.7 39.1%   
Total wages/salary Rs m1,445607 238.3%   
Avg. sales/employee Rs Th8,441.32,436.7 346.4%   
Avg. wages/employee Rs Th2,163.6355.2 609.2%   
Avg. net profit/employee Rs Th1,173.172.5 1,617.1%   
INCOME DATA
Net Sales Rs m5,6394,162 135.5%  
Other income Rs m1,71861 2,807.7%   
Total revenues Rs m7,3574,223 174.2%   
Gross profit Rs m-63197 -31.7%  
Depreciation Rs m2532 79.8%   
Interest Rs m5530 184.9%   
Profit before tax Rs m1,575197 800.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m79273 1,087.4%   
Profit after tax Rs m784124 632.4%  
Gross profit margin %-1.14.7 -23.4%  
Effective tax rate %50.337.0 135.8%   
Net profit margin %13.93.0 466.8%  
BALANCE SHEET DATA
Current assets Rs m9,5221,629 584.6%   
Current liabilities Rs m3,2961,058 311.6%   
Net working cap to sales %110.413.7 804.8%  
Current ratio x2.91.5 187.6%  
Inventory Days Days3730 123.0%  
Debtors Days Days2834 84.6%  
Net fixed assets Rs m46556 8.3%   
Share capital Rs m12378 158.8%   
"Free" reserves Rs m7,213878 821.2%   
Net worth Rs m7,3361,069 686.1%   
Long term debt Rs m0159 0.0%   
Total assets Rs m11,1052,399 462.8%  
Interest coverage x29.57.6 389.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.51.7 29.3%   
Return on assets %7.66.4 117.9%  
Return on equity %10.711.6 92.2%  
Return on capital %22.218.5 120.4%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m6133 184.2%   
Fx outflow Rs m3,63063 5,744.9%   
Net fx Rs m-3,570-30 11,784.7%   
CASH FLOW
From Operations Rs m1,610127 1,271.6%  
From Investments Rs m687-146 -470.5%  
From Financial Activity Rs m-2,67722 -12,221.5%  
Net Cashflow Rs m-3803 -15,184.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 3.7 54.1%  
FIIs % 1.6 5.2 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.8 83.3%  
Shareholders   41,647 12,723 327.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Yes Bank & Tata Motors Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Nov 19, 2018 01:15 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS